glp 1 agonist lilly The GLP-1 market is projected to exceed 100B USD by 2030 GLP-1s & Beyond: Understanding Incretin
Description
These help you feel full and keep blood sugar stable
Improved HbA1c: GLP-1 drugs consistently reduce HbA1c an important long-term marker of diabetes control often by 11.5%, depending on the agent and dose
Insurance may cover with prior authorization
Many people are watching closely to see if the state will maintain its role as a leader in health equity
